# Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

> **NCT00477503** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Central Nervous System Tumors
- Brain Tumors

## Interventions

- **DRUG:** Gallium-67 Citrate (Ga-67)
- **DRUG:** In-111 DTPA (In-111 pentetate)

## Key facts

- **NCT ID:** NCT00477503
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** One participant enrolled, study terminated .
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477503, "Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00477503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*